Betahistine mesylate

CAS No. 54856-23-4

Betahistine mesylate ( —— )

Catalog No. M14976 CAS No. 54856-23-4

Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière’s disease.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 26 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Betahistine mesylate
  • Note
    Research use only, not for human use.
  • Brief Description
    Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière’s disease.
  • Description
    Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière’s disease. It is also commonly used for patients with balance disorders.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    H1 receptor; H3 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    54856-23-4
  • Formula Weight
    328.40
  • Molecular Formula
    C8H12N2·2(CH4O3S)
  • Purity
    >98%(HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    CS(O)(=O)=O.CS(O)(=O)=O.CNCCC1=CC=CC=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lacour M, Sterkers O. CNS Drugs. 2001; 15(11): 853-70.
molnova catalog
related products
  • Rupatadine Fumarate

    Rupatadine is an inhibitor of PAFR and histamine (H1) receptor with Ki of 550 nM and 102 nM, respectively.

  • Fexofenadine

    Fexofenadine, an antihistamine pharmaceutical drug, is used to treat allergy symptoms, such as nasal congestion, hay fever, and urticaria.

  • Betazole hydrochlori...

    Betazole hydrochloride is an agonist of H2 receptor.